Viewing Study NCT03707457


Ignite Creation Date: 2025-12-24 @ 6:40 PM
Ignite Modification Date: 2026-02-19 @ 3:39 AM
Study NCT ID: NCT03707457
Status: TERMINATED
Last Update Posted: 2020-07-02
First Post: 2018-10-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Biomarker-Driven Therapy Using Immune Activators With Nivolumab in Patients With First Recurrence of Glioblastoma
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module